Screener
10x Genomics, Inc. TXG Single Cell — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Spatial | 4,574 | 8,770 | 10,613 | 17,672 |
| Total instruments revenue | 7,661 | 14,497 | 18,923 | 29,312 |
| Consumables | ||||
| Single Cell | 88,451 | 85,788 | 177,345 | 169,897 |
| Spatial | 42,301 | 36,397 | 83,208 | 67,644 |
| Total consumables revenue | 130,752 | 122,185 | 260,553 | 237,541 |
| Services | 10,681 | 8,475 | 19,514 | 16,127 |
| Products and services revenue | 149,094 | 145,157 | 298,990 | 282,980 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s single cell — revenue?
- 10x Genomics, Inc. (TXG) reported single cell — revenue of $88.45M in Q2 2026.
- How has 10x Genomics, Inc.'s single cell — revenue changed year-over-year?
- 10x Genomics, Inc.'s single cell — revenue increased by 3.1% year-over-year, from $85.79M to $88.45M.
- What is the long-term trend for 10x Genomics, Inc.'s single cell — revenue?
- Over 3 years (2021 to 2024), 10x Genomics, Inc.'s single cell — revenue has grown at a -1.6% compound annual growth rate (CAGR), from $390.88M to $372.31M.
- What does single cell — revenue mean?
- This metric represents the total revenue generated from the sale of instruments, consumables, and software associated with the company's primary genomic analysis platform. It serves as a key indicator of the adoption and utilization rates of the core technology within the life sciences research market. Tracking this revenue stream helps investors assess the commercial performance and market penetration of the company's flagship product line.
Ask your AI about 10x Genomics, Inc.'s single cell — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude